Clorox Reports Fourth Quarter and Fiscal Year 2021 Results, Provides Fiscal Year 2022 Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Dow tick higher as investors weigh Mideast negotiations
- Oil falls after US-Iran talks signal easing supply risks
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Clorox (CLX) Falls Sharply as COVID-19 Demand Wanes
August 3, 2021 7:59 AM EDTShares of Clorox (NYSE: CLX) are down about 10% in pre-open Tuesday after the company saw fading demand for its products.
The companys biggest unit by revenue generated, the health and wellness division, witnessed a 17% decline in sales. The company recorded falling sales in three out of four business divisions as pandemic-shaped demand for Clorox waned.
Overall, sales... More
Clorox (CLX) Misses Q4 EPS by 41c, Guidance Falls Short of Consensus
August 3, 2021 6:36 AM EDTClorox (NYSE: CLX) reported Q4 EPS of $0.95, $0.41 worse than the analyst estimate of $1.36. Revenue for the quarter came in at $1.8 billion versus the consensus estimate of $1.92 billion.
GUIDANCE:
Clorox sees FY2022 EPS of $5.40-$5.70, versus the consensus of $7.61.
2% to... More